National and Georgia leaders spanning government, financial, life science industry and academia joined Micron Biomedical employees and partners at a ribbon-cutting ceremony celebrating the opening of a 26,000 square foot facility in Alpharetta, Georgia. The opening marks the most advanced commercial-scale manufacturing site for Micron Biomedical’s dissolvable vaccine and therapeutic technology in the world and positions the company for pivotal clinical trials that will accelerate the availability of needle-free vaccines and therapeutics that can be self-administered at home.
National and Georgia leaders spanning government, financial, life science industry and academia joined Micron Biomedical employees and partners at a ribbon-cutting ceremony celebrating the opening of a 26,000 square foot facility in Alpharetta, Georgia. The opening marks the most advanced commercial-scale manufacturing site for Micron Biomedical’s dissolvable vaccine and therapeutic technology in the world and positions the company for pivotal clinical trials that will accelerate the availability of needle-free vaccines and therapeutics that can be self-administered at home.